Company intelligence / Profile preview

Harpe Bioherbicide Solutions

Raleigh, North Carolina, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Harpe has demonstrated broad-spectrum weed control in over 1,000 trials worldwide using novel plant extract-based formulations effective against resistant weeds; product field testing ongoing, targeting commercial launch in 2026[10].

Therapeutic areas: Other
Modalities: Plant extractSmall molecule
Industry: Agriculture & AgTech

Partnerships

Corteva Agriscience (IP licensing, trait development)[3][10]Broad Institute of MIT and Harvard (CRISPR technology development)[3][10]Solis Agrosciences (crop trait R&D)[3][10]ADM (investment, mint supply, strategic commercial partner)[5]

Beyond the preview

Go deeper on Harpe Bioherbicide Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harpe Bioherbicide Solutions.

Explore the full profile